PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Aminaphtone→

Aminaphtone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
14748-94-8
Molecular formula
C18H15NO4
Molecular weight
309.3 g/mol
Drug class
Vasoprotective agentcapillary-stabilising naphthoquinone derivative
Mechanism of action
Proposed to reduce capillary permeability and fragility and improve microcirculatory function. The exact molecular mechanism and strength of clinical evidence are not fully established.
Indications / reported uses
  • Symptomatic treatment of chronic venous insufficiency and capillary fragility in countries where aminaphtone products are authorised; use should follow current national product information

Sources: NLM MeSH — Aminaphtone · PubMed — Aminaphtone chronic venous insufficiency · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Aminaphtone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Aminaphtone Permitted Daily Exposure (PDE) report (the Aminaphtone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Aminaphtone Occupational Exposure Limit (OEL) report (the Aminaphtone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.